Table 1.
Clinical characteristics of the patients, receiving propylene glycol co-administered with paracetamol, phenobarbital or both, presented as median (range)
| Characteristics | Paracetamol | Phenobarbital | Paracetamol + Phenobarbital |
|---|---|---|---|
| Number of patients | 34 | 25 | 3 |
| Gestational age (weeks) | 38 (24–41) | 34 (27–40) | 36 (35–37) |
| Postmenstrual age (weeks) | 38 (25–41) | 34 (28–46) | 36 (35–37) |
| Postnatal age (days) | 3 (1–28) | 2 (1–82) | 3 (2–5) |
| Birth weight (g) | 2990 (630–3820) | 1965 (815–3980) | 2490 (2245–2514) |
| Current bodyweight (g) | 2990 (700–4100) | 1965 (780–3980) | 2435 (2145–2490) |
Birth weight, weight at day of birth; current bodyweight, weight at day of blood sampling.